Gene · 5550
Papers2,494
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,494
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Patients With Pancreatitis-Related Gene Variants Showed Higher Incidence of Hyperpancreatic Enzymemia After Endoscopic Retrograde Cholangiopancreatography. | DEN Open | 2027 | 42058267 | PubTator, text mining | PubMed |
| Structure-based optimization, in vitro profiling, and ADMET prediction of Celastrol derivatives as potent prolyl endopeptidase inhibitors. | Bioorg Chem | 2026 | 42673716 | PubTator, text mining | PubMed |
| FAP-Inhibitor Homodimers with Engineered Linker-Spacer Units: Toward Optimized Radiopharmaceuticals. | ACS Omega | 2026 | 42662658 | PubTator, text mining | PubMed |
| Seed-Guided De Novo Design Expands the Structural Diversity of Antitoxin Protein Binders. | bioRxiv | 2026 | 42620311 | PubTator, text mining | PubMed |
| Bridging linguistic reasoning and biophysical reality toward peptide engineering via instruction-tuned language modeling. | Bioinformatics | 2026 | 42608825 | PubTator, text mining | PubMed |
| Perioperative pancreatic ductal adenocarcinoma care in 2025: who needs neoadjuvant?-who needs radiation? | Gland Surg | 2026 | 42591952 | PubTator, text mining | PubMed |
| Novel aspects of the renin-angiotensin-aldosterone system in septic shock. | Curr Opin Physiol | 2026 | 42534273 | PubTator, text mining | PubMed |
| A new series of FAP inhibitors for cancer imaging based on 8-substituted (4-quinolinoyl)-glycyl-2-cyanopyrrolidine. | Nucl Med Biol | 2026 | 42526425 | PubTator, text mining | PubMed |
| Identification of biallelic loss-of-function PREP variants in three individuals with syndromic intellectual disability. | J Med Genet | 2026 | 42362369 | PubTator, text mining | PubMed |
| Mass spectrometry-based proteomic profiling of human tauopathy brains suggests mitochondria-associated alterations. | Front Mol Neurosci | 2026 | 42254865 | PubTator, text mining | PubMed |
| P-glycoprotein-mediated efflux of rapaprotin-L dictates sensitivity of cancer cells to the inducer of 26S proteasome disassembly. | Eur J Pharmacol | 2026 | 42217720 | PubTator, text mining | PubMed |
| Proline-Based Structural Rules for Predicting Prolyl Endopeptidase Inhibitory Peptides from Food Proteins: In Vitro Validation and Multiscale Computational Characterization. | J Agric Food Chem | 2026 | 42183829 | PubTator, text mining | PubMed |
| Targeted enzymatic therapy for coeliac disease. | EMBO Mol Med | 2026 | 42135567 | PubTator, text mining | PubMed |
| Tropical psychotria plants are a rich source for peptide inhibitors of human prolyl oligopeptidase. | Nat Prod Bioprospect | 2026 | 41975038 | PubTator, text mining | PubMed |
| Optimizing precision in quantum metrology through engineered environments. | Sci Rep | 2026 | 41912613 | PubTator, text mining | PubMed |
| The potential effect and pathway of valsartan: genome-wide and phenome-wide association study from UK Biobank data. | Pharmacogenet Genomics | 2026 | 41861149 | PubTator, text mining | PubMed |
| Investigating the oncogenic potential of MTHFD2 in oral squamous cell carcinoma. | J Cancer Res Clin Oncol | 2026 | 41831033 | PubTator, text mining | PubMed |
| Overcoming claudin family homology: discovery of ARC101, a highly potent CLDN6-specific T-cell engager with a novel CD3 binder for ovarian adenocarcinoma. | MAbs | 2026 | 41804857 | PubTator, text mining | PubMed |
| Targeting the proline-glycine-proline-protease feed-forward loop attenuates primary graft dysfunction after lung transplantation. | Front Immunol | 2026 | 41798933 | PubTator, text mining | PubMed |
| Zinc Coordination by Thymosin β4: Structural Determinants and Functional Implications. | Int J Mol Sci | 2026 | 41751875 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5550/papers